A recent genome-wide survival study of AD onset convincingly demonstrated that transcription factor (TF) PU.1 encoded by SPI1 is a key regulator for the development and function of myeloid cells and lower SPI1 expression delays the onset of AD by regulating gene expression in myeloid cells [43]. This evidence concerns the gene TF and Alzheimer disease.